Comparison of Two Different Methods for Measurement of Amyloid-β Peptides in Cerebrospinal Fluid after BACE1 Inhibition in a Dog Model

被引:13
作者
Borghys, Herman [1 ]
Jacobs, Tom [1 ]
Van Broeck, Bianca [1 ]
Dillen, Lieve [1 ]
Dhuyvetter, Deborah [1 ]
Gijsen, Harrie [1 ]
Mercken, Marc [1 ]
机构
[1] Pharmaceut Co Johnson & Johnson, Janssen Res & Dev, Beerse, Belgium
关键词
Alzheimer's disease; amyloid-beta peptides; beta-secretase; cerebrospinal fluid; dog; ALZHEIMERS-DISEASE; CANINE MODEL; MS/MS METHOD; SECRETASE; BRAIN;
D O I
10.3233/JAD-130599
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Beta-secretase is the first cleavage enzyme of amyloid-beta protein precursor (A beta PP) in the amyloidogenic pathway, leading to the formation of the plaque forming Amyloid-beta (A beta)(1-42) peptide. BACE(beta-site A beta PP cleaving enzyme) 1 inhibition is therefore considered to be a promising disease modifying therapy for Alzheimer's disease. An early assessment of the in vivo activity of BACE inhibitors was done in dogs since A beta PP processing is the same as in humans and this species easily enables longitudinal cerebrospinal fluid (CSF) sampling. A beta changes in CSF compared to baseline are used to evaluate target engagement of the compounds. Levels of A beta(1-37), A beta(1-38), A beta(1-40), and A beta(1-42) in CSF are measured with immunoassay (Mesoscale electrochemiluminescence technology) and with an ultra high-performance liquid chromatography mass spectrometry (UPLC-MS/MS). Two experimental BACE inhibitors were evaluated. With the immunoassay, a dose dependent decrease is observed for all four A beta peptides. Measurements with the UPLC-MS/MS are in line with the immunoassay for A beta(1-37), A beta(1-38), and A beta(1-40,) however, for A beta(1-42), differences are sometimes observed when comparing to changes seen in the other peptides with UPLC-MS/MS and with immunoassay results. Generally lower concentrations are measured with immunoassay. The reason for these differences is still unknown. A beta(1-42) is more prone to form aggregates compared to the other peptides. One hypothesis could be that while the immunoassay only measures free A beta, bound and aggregated A beta peptides are at least partially dissolved with the UPLC-MS/MS method, since acetonitrile is added to the CSF samples. This increases variability in the concentration of A beta peptide measured with UPLC-MS/MS, especially for A beta(1-42), potentially masking the compound effect on A beta(1-42) levels.
引用
收藏
页码:39 / 48
页数:10
相关论文
共 26 条
[1]   Cerebrospinal fluid flow imaging by using phase-contrast MR technique [J].
Battal, B. ;
Kocaoglu, M. ;
Bulakbasi, N. ;
Husmen, G. ;
Sanal, H. Tuba ;
Tayfun, C. .
BRITISH JOURNAL OF RADIOLOGY, 2011, 84 (1004) :758-765
[2]   Amyloid β-protein (Aβ) assembly:: Aβ40 and Aβ42 oligomerize through distinct pathways [J].
Bitan, G ;
Kirkitadze, MD ;
Lomakin, A ;
Vollers, SS ;
Benedek, GB ;
Teplow, DB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (01) :330-335
[3]  
Bjerke Maria, 2010, Int J Alzheimers Dis, V2010, DOI 10.4061/2010/986310
[4]   A Canine Model to Evaluate Efficacy and Safety of γ-Secretase Inhibitors and Modulators [J].
Borghys, Herman ;
Tuefferd, Marianne ;
Van Broeck, Bianca ;
Clessens, Ellen ;
Dillen, Lieve ;
Cools, Willy ;
Vinken, Petra ;
Straetemans, Roel ;
De Ridder, Filip ;
Gijsen, Harrie ;
Mercken, Marc .
JOURNAL OF ALZHEIMERS DISEASE, 2012, 28 (04) :809-822
[5]   The Role of Amyloid Precursor Protein Processing by BACE1, the β-Secretase, in Alzheimer Disease Pathophysiology [J].
Cole, Sarah L. ;
Vassar, Robert .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (44) :29621-29625
[6]  
Cotman CW, 2008, J ALZHEIMERS DIS, V15, P685
[7]   Macromolecules involved in production and metabolism of beta-amyl oid at the brain barriers [J].
Crossgrove, Janelle S. ;
Smith, Ellen L. ;
Zheng, Wei .
BRAIN RESEARCH, 2007, 1138 :187-195
[8]   The choroid plexus removes β-amyloid from brain cerebrospinal fluid [J].
Crossgrove, JS ;
Li, GJ ;
Zheng, W .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2005, 230 (10) :771-776
[9]  
de Lahunta A., 2014, VET NEUROANATOMY CLI, P102
[10]  
Dhuyvetter D, 2012, SOC NEUR ABSTR